Association between self-replicating calcifying nanoparticles and aortic stenosis: A possible link to valve calcification

European Heart Journal

Volumn 29, Issue 3, 2008, Pages 371-376

  Bratos Pérez, Miguel A ^a   Sánchez, Pedro L ^b   García De Cruz, Susana ^a   Villacorta, Eduardo ^a   Palacios, Igor F ^c   Fernández Fernández, José M ^a   Di Stefano, Salvatore ^a   Orduña Domingo, Antonio ^a   Carrascal, Yolanda ^a   Mota, Pedro ^a   Martín Luengo, Cándido ^d   Bermejo, Javier ^b   San Roman, José A ^a   Rodríguez Torres, Antonio ^a   Fernández Avilés, Francisco ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Aortic stenosis; Calcification; Calcifying nanoparticles; Nanobacteria

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NANOPARTICLE;

ADULT; AGED; AORTA STENOSIS; ARTICLE; CALCIFYING NANOPARTICLE; CONTROL GROUP; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART GRAFT; HEART VALVE CALCIFICATION; HEART VALVE REPLACEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; MORPHOLOGY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOFT TISSUE CALCIFICATION; STATISTICAL SIGNIFICANCE; TISSUE CULTURE;

AGED; AORTIC VALVE STENOSIS; BACTERIA; CALCINOSIS; CASE-CONTROL STUDIES; CULTURE TECHNIQUES; FEMALE; HUMANS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; NANOPARTICLES;

EID: 38849090642     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm592     Document Type: Article

References (36)

1. Carabello BA. Evaluation and management of patients with aortic stenosis. Circulation 2002;105:1746-1750.
2. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-1011.
3. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM. Clinical factors associated with calcific aortic valve disease Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630-634.
4. Liebe V, Brueckmann M, Borggrefe M, Kaden JJ. Statin therapy of calcific aortic stenosis: hype or hope? Eur Heart J 2006;27:773-778.
5. Rajamannan NM, Gersh B, Bonow RO. Calcific aortic stenosis: from bench to the bedside - emerging clinical and cellular concepts. Heart 2003;89:801-805.
6. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316-3326.
7. Sanchez PL, Santos JL, Kaski JC, Cruz I, Arribas A, Villacorta E, Cascon M, Palacios IF, Martin-Luengo CGrupo AORTICA (Grupo de Estudio de la Estenosis Aortica). Relation of circulating C-reactive protein to progression of aortic valve stenosis. Am J Cardiol 2006;97:90-93.
8. Chan KL. Is aortic stenosis a preventable disease? J Am Coll Cardiol 2003;42:593-599.
9. Miller VM, Lieske JC, Salahudeen AK. Introduction to pathologic calcification: crystallization, infection, or cellular transdifferentiation. J Investig Med 2006;54:365-366.
10. Kajander EO, Ciftcioglu N. Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci USA 1998;95:8274-8279.
11. Cisar JO, Xu DQ, Thompson J, Swaim W, Hu L, Kopecko DJ. An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci USA 2000;97:11511-11515.
12. Ciftcioglu N, Bjorklund M, Kuorikoski K, Bergstrom K, Kajander EO. Nanobacteria: an infectious cause for kidney stone formation. Kidney Int 1999;56:1893-1898.
13. Bjorklund M, Ciftcioglu N, Kajander EO. Extraordinary survival of nanobacteria under extreme conditions. Proc SPIE 1997;3111:123- 129.
14. Wen Y, Li YG, Yang ZL, Wang XJ, Wei H, Liu W, Miao XY, Wang QW, Huang SF, Yang J, Kajander EO, Ciftcioglu N. Detection of nanobacteria in serum, bile and gallbladder mucosa of patients with cholecystolithiasis. Chin Med J (Engl) 2005;118:421-424.
15. Hudelist G, Singer CF, Kubista E, Manavi M, Mueller R, Pischinger K, Czerwenka K. Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization. Histopathology 2004;45:633-637.
16. Kajander EO, Kuronen I, Akerman K, Pelttari A, Ciftcioglu N. Nanobacteria from blood, the smallest culturable autonomously replicating agent on earth. Proc SPIE 1997;3111:420-428.
17. Ciftcioglu N, Pelttari A, Kajander EO. Extraordinary growth phases of nanobacteria isolated from mammalian blood. Proc SPIE 1997;3111:429-435.
18. Jelic TM, Malas AM, Groves SS, Jin B, Mellen PF, Osborne G, Roque R, Rosencrance JG, Chang HH. Nanobacteria-caused mitral valve calciphylaxis in a man with diabetic renal failure. South Med J 2004;97:194-198.
19. Miller VM, Rodgers G, Charlesworth JA, Kirkland B, Severson SR, Rasmussen TE, Yagubyan M, Rodgers JC, Cockerill FR III, Folk RL, Rzewuska-Lech E, Kumar V, Farell-Baril G, Lieske JC. Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol 2004;287:H1115-H1124.
20. Jelic TM, Chang HH, Roque R, Malas AM, Warren SG, Sommer AP. Nanobacteria-associated calcific aortic valve stenosis. J Heart Valve Dis 2007;16:101-105.
21. Puskas LG, Tiszlavicz L, Razga Z, Torday LL, Krenacs T, Papp JG. Detection of nanobacteria-like particles in human atherosclerotic plaques. Acta Biol Hung 2005;56:233-245.
22. Ciftcioglu N, McKay DS, Mathew G, Kajander EO. Nanobacteria: fact or fiction? Characteristics, detection, and medical importance of novel self-replicating, calcifying nanoparticles. J Investig Med 2006;54:385-394.
23. Drancourt M, Jacomo V, Lepidi H, Lechevallier E, Grisoni V, Coulange C, Ragni E, Alasia C, Dussol B, Berland Y, Raoult D. Attempted isolation of Nanobacterium sp. microorganisms from upper urinary tract stones. J Clin Microbiol 2003;41:368-372.
24. Benzerara K, Miller VM, Barell G, Kumar V, Miot J, Brown GE Jr, Lieske JC. Search for microbial signatures within human and microbial calcifications using soft x-ray spectromicroscopy. J Investig Med 2006;54:367- 379.
25. Hjelle JT, Miller-Hjelle MA, Poxton IR, Kajander EO, Ciftcioglu N, Jones ML, Caughey RC, Brown R, Millikin PD, Darras FS. Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int 2000;57:2360-2374.
26. Ertas FS, Hasan C, Ozdol O, Akan C, Tulunay T, Kocum S, Uysal I, Dincer M, Sahin Y, Atmaca N, Ciftcioglu N, Kajander EO, Erol C. Association between nanobacteria and aortic valve calcification. Eur Heart J 2006;27:745.
27. Wang L, Shen W, Wen J, An X, Cao L, Wang B. An animal model of black pigment gallstones caused by nanobacteria. Dig Dis Sci 2006;51:1126-1132.
28. Zhou HD, Li GY, Yang YX, Li XL, Sheng SR, Zhang WL, Zhao J. Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain. Mol Immunol 2006;43:1864-1871.
29. Ciftcioglu N, Miller-Hjelle MA, Hjelle JT, Kajander EO. Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother 2002;46:2077-2086.
30. Shiekh FA, Khullar M, Singh SK. Lithogenesis: induction of renal calcifications by nanobacteria. Urol Res 2006;34:53-57.
31. Kajander EO, Ciftcioglu N, Aho K, Garcia-Cuerpo E. Characteristics of nanobacteria and their possible role in stone formation. Urol Res 2003;31:47-54.
32. Kim BH, Park HS, Kim HJ, Kim GT, Chang IS, Lee J, Phung NT. Enrichment of microbial community generating electricity using a fuel-cell-type electrochemical cell. Appl Microbiol Biotechnol 2004;63:672-681.
33. Cohen DJ, Malave D, Ghidoni JJ, Iakovidis P, Everett MM, You S, Liu Y, Boyan BD. Role of oral bacterial flora in calcific aortic stenosis: an animal model. Ann Thorac Surg 2004;77:537-543.
34. Ciftcioglu N, McKay DS, Kajander EO. Association between nanobacteria and periodontal disease. Circulation 2003;108:e58-e59. Author reply e58-e59.
35. Maniscalco BS, Taylor KA. Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy. Pathophysiology 2004;11:95-101.
36. Kraemer MA, Farell-Baril G, Lieske JC, Miller VM. Biologic nanoparticles and arterial response of injury. FASEB J 2007;21:744.1.